Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Hou

Showing results (681-690 of 713) with videos related to

Pageof 72
Sort By:
ACS Applied Bio Materials|June 4, 2024
Cracking the Code: Enhancing Molecular Tools for Progress in NanobiotechnologyYelixza I Avila, Laura P Rebolledo, Elizabeth Skelly, et al.
Blood|January 11, 2015
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITPHai Zhou, Miao Xu, Ping Qin, et al.
American Journal of Human Genetics|October 6, 2010
Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathyHeather M McLaughlin, Reiko Sakaguchi, Cuiping Liu, et al.
Frontiers in Oncology|July 25, 2022
Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201)Yuqin Song, Keshu Zhou, Chuan Jin, et al.
American Journal of Hematology|September 2, 2020
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trialYafei Yu, Miaomiao Wang, Yu Hou, et al.
The Journal of Clinical Investigation|September 27, 2019
Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse modelsKathryn H Morelli, Laurie B Griffin, Nettie K Pyne, et al.
Leukemia & Lymphoma|October 16, 2014
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosisChul Won Jung, Lee-Yung Shih, Zhijian Xiao, et al.
American Journal of Human Genetics|March 3, 2019
Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and NailsMolly E Kuo, Arjan F Theil, Anneke Kievit, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in ChinaHu Zhou, Jianfeng Zhou, Depei Wu, et al.
ACS Pharmacology & Translational Science|March 29, 2020
Stabilization of Cyclin-Dependent Kinase 4 by Methionyl-tRNA Synthetase in p16<sup>INK4a</sup>-Negative CancerNam Hoon Kwon, Jin Young Lee, Ye-Lim Ryu, et al.
Pageof 72

Showing results (681-690 of 713) with videos related to

Sort By:
Pageof 72
ACS Applied Bio Materials|June 4, 2024
Cracking the Code: Enhancing Molecular Tools for Progress in NanobiotechnologyYelixza I Avila, Laura P Rebolledo, Elizabeth Skelly, et al.
Blood|January 11, 2015
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITPHai Zhou, Miao Xu, Ping Qin, et al.
American Journal of Human Genetics|October 6, 2010
Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathyHeather M McLaughlin, Reiko Sakaguchi, Cuiping Liu, et al.
Frontiers in Oncology|July 25, 2022
Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201)Yuqin Song, Keshu Zhou, Chuan Jin, et al.
American Journal of Hematology|September 2, 2020
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trialYafei Yu, Miaomiao Wang, Yu Hou, et al.
The Journal of Clinical Investigation|September 27, 2019
Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse modelsKathryn H Morelli, Laurie B Griffin, Nettie K Pyne, et al.
Leukemia & Lymphoma|October 16, 2014
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosisChul Won Jung, Lee-Yung Shih, Zhijian Xiao, et al.
American Journal of Human Genetics|March 3, 2019
Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and NailsMolly E Kuo, Arjan F Theil, Anneke Kievit, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in ChinaHu Zhou, Jianfeng Zhou, Depei Wu, et al.
ACS Pharmacology & Translational Science|March 29, 2020
Stabilization of Cyclin-Dependent Kinase 4 by Methionyl-tRNA Synthetase in p16<sup>INK4a</sup>-Negative CancerNam Hoon Kwon, Jin Young Lee, Ye-Lim Ryu, et al.
Pageof 72